Corning Incorporated has launched Corning® Viridian™ Vials, the latest innovation in its expanding pharmaceutical glass-packaging portfolio. Viridian Vials bring performance and sustainability together. The new technology can improve filling-line efficiency by up to 50 percent while reducing vial-manufacturing carbon-dioxide-equivalent (CO2e) emissions by up to 30 percent.
“Corning continues to push the boundaries of glass technology to help our customers tackle their most complex challenges,” said Ron Verkleeren, senior vice president and general manager of Corning Life Sciences. “Viridian Vials’ cutting-edge coating technology allows our customers to deliver medications safely and efficiently – for both patients and the planet.”
Injectable medicines play an increasingly important role in global health. As demand for these medicines rises, pharmaceutical manufacturers are looking to increase production efficiently while reducing the environmental impact of their supply chain.
Viridian Vials use 20 percent less glass material than conventional glass vials, with no impact on the quality or safety of the vial. This reduction in glass material lowers manufacturing and transportation-related emissions by up to 30 percent and decreases the total amount of glass entering the waste stream. In addition, Viridian’s low-friction external coating minimizes cracks, breaks, and cosmetic rejects while improving filling-line efficiency by up to 50 percent.
“With Viridian, we’ve created a drop-in solution that’s compatible with today’s equipment and standards – and that helps our customers achieve their sustainability goals,” continued Verkleeren.
West Pharmaceutical Services will be the exclusive distributor of Viridian Vial Technology. Corning’s ongoing collaboration with West brings together two industry leaders with a shared commitment to using resources responsibly to help create a healthier, more sustainable world.